Stay updated on Secukinumab Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.1.SummaryDifference1%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a clinical study on Secukinumab for atopic dermatitis, while retaining the names of collaborators and the principal investigator.SummaryDifference39%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Secukinumab Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page.